0001209191-20-063655.txt : 20201215 0001209191-20-063655.hdr.sgml : 20201215 20201215204919 ACCESSION NUMBER: 0001209191-20-063655 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201211 FILED AS OF DATE: 20201215 DATE AS OF CHANGE: 20201215 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Menard Chrystal CENTRAL INDEX KEY: 0001564252 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21937 FILM NUMBER: 201391075 MAIL ADDRESS: STREET 1: C/O CERUS CORPORATION STREET 2: 2550 STANWELL DRIVE CITY: CONCORD STATE: CA ZIP: 94520 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CERUS CORP CENTRAL INDEX KEY: 0001020214 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 680262011 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1220 CONCORD AVENUE STREET 2: SUITE 600 CITY: CONCORD STATE: CA ZIP: 94520 BUSINESS PHONE: 9252886000 MAIL ADDRESS: STREET 1: 1220 CONCORD AVENUE STREET 2: SUITE 600 CITY: CONCORD STATE: CA ZIP: 94520 FORMER COMPANY: FORMER CONFORMED NAME: CERUS TECHNOLOGIES INC DATE OF NAME CHANGE: 19960731 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-12-11 0 0001020214 CERUS CORP CERS 0001564252 Menard Chrystal C/O CERUS CORPORATION 1220 CONCORD AVE SUITE 600 CONCORD CA 94520 0 1 0 0 Chief Legal Officer Common Stock 2020-12-11 4 M 0 4167 4.33 A 52742 D Common Stock 2020-12-11 4 S 0 4167 8.00 D 48585 D Common Stock 2020-12-11 4 M 0 3959 4.32 A 52544 D Common Stock 2020-12-11 4 S 0 3959 8.00 D 48585 D Common Stock 2020-12-11 4 M 0 11362 4.46 A 59947 D Common Stock 2020-12-11 4 S 0 11362 8.00 D 48585 D Common Stock 2020-12-11 4 M 0 21875 4.46 A 70460 D Common Stock 2020-12-11 4 S 0 21875 8.00 D 48585 D Option (Right to Buy) 4.33 2020-12-11 4 M 0 4167 D 2027-02-28 Common Stock 4167 95833 D Option (Right to Buy) 4.32 2020-12-11 4 M 0 3959 D 2028-02-28 Common Stock 3959 91041 D Option (Right to Buy) 4.46 2020-12-11 4 M 0 11362 D 2025-03-01 Common Stock 11362 68516 D Option (Right to Buy) 4.46 2020-12-11 4 M 0 21875 D 2025-03-01 Common Stock 21875 0 D This transaction was executed pursuant to a 10b5-1 plan. One eighth (1/8th) of the shares subject to the Option vested six (6) months after the grant date, and one forty-eighth (1/48th) of the shares subject to the Option vested each month thereafter. Not applicable. Chrystal Menard 2020-12-15